{"id":61753,"date":"2026-05-07T16:16:09","date_gmt":"2026-05-07T16:16:09","guid":{"rendered":"https:\/\/www.europesays.com\/ch\/61753\/"},"modified":"2026-05-07T16:16:09","modified_gmt":"2026-05-07T16:16:09","slug":"dr-reddys-nestle-health-science-launches-celevida-glp-plus-2","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ch\/61753\/","title":{"rendered":"Dr. Reddy\u2019s &#038; Nestle Health Science launches Celevida\u00a0GLP Plus"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/www.europesays.com\/ch\/wp-content\/uploads\/2026\/03\/1773817933_534_1x1_spacer.png\" alt=\"Celevida\u00a0GLP+ is available in\u00a0a\u00a0350\u00a0g pack\u00a0across pharmacies, retail outlets, and leading e-commerce platforms.\u00a0\" title=\"Celevida\u00a0GLP+ is available in\u00a0a\u00a0350\u00a0g pack\u00a0across pharmacies, retail outlets, and leading e-commerce platforms.\u00a0\" data-original=\"https:\/\/www.europesays.com\/ch\/wp-content\/uploads\/2026\/03\/1773817933_534_1x1_spacer.png\" class=\"article-pictue\"\/><\/p>\n<p class=\"caption\">\n\t\t\t\t\t\t\t\t\t\tCelevida\u00a0GLP+ is available in\u00a0a\u00a0350\u00a0g pack\u00a0across pharmacies, retail outlets, and leading e-commerce platforms.\u00a0<br \/>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t| Photo Credit:<br \/>\n\t\t\t\t\t\t\t\t\t\t\tSrikrishnan PC\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/p>\n<p>Dr Reddy\u2019s and Nestl\u00e9 Health Science, a joint venture between\u00a0Dr. Reddy\u2019s Laboratories and Nestle India, launched Celevida\u00a0GLP Plus in the domestic market.\u00a0<\/p>\n<p>It is a specialised product to support optimum nutrition intake and muscle mass maintenance for sustaining metabolic and functional health for\u00a0people\u00a0undergoing GLP-1\/GIP therapy\u00a0for management of type 2 diabetes and obesity.<\/p>\n<p>\u201cGLP-1 therapies represent a significant advancement in diabetes and obesity management. However, a clear unmet need remains in supporting patients beyond pharmacological treatment, particularly in addressing nutrition gaps and preserving muscle health during therapy. With Celevida\u00a0GLP+, we aim to address this gap,\u2019\u2019\u00a0\u00a0M.V. Ramana, CEO, Global Generics\u00a0at\u00a0Dr.\u00a0Reddy\u2019s\u00a0Laboratories\u00a0and Director, Dr. Reddy\u2019s and Nestl\u00e9 Health Science said in a release on Thursday.\u00a0<\/p>\n<p>Celevida\u00a0GLP+ is available in\u00a0a\u00a0350\u00a0g pack\u00a0across pharmacies, retail outlets, and leading e-commerce platforms.\u00a0<\/p>\n<p>GLP-1\/GIP therapy refers to a class of medicines that mimic two natural gut hormones\u2014GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide)\u2014to help regulate blood sugar, appetite, and body weight.\u00a0\u00a0<\/p>\n<p class=\"publish-time\" id=\"end-of-article\">Published on  May 7, 2026 <\/p>\n","protected":false},"excerpt":{"rendered":"Celevida\u00a0GLP+ is available in\u00a0a\u00a0350\u00a0g pack\u00a0across pharmacies, retail outlets, and leading e-commerce platforms.\u00a0 | Photo Credit: Srikrishnan PC Dr&hellip;\n","protected":false},"author":2,"featured_media":61665,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[126],"tags":[33971,33970,33972,26551,199,7073,33973],"class_list":{"0":"post-61753","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-nestle","8":"tag-celevida-glp","9":"tag-dr-reddys","10":"tag-gip-therapy","11":"tag-glp-1","12":"tag-nestle","13":"tag-nestle-health-science","14":"tag-type-2-diabetes"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ch\/116534194112552697","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/61753","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/comments?post=61753"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/61753\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media\/61665"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media?parent=61753"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/categories?post=61753"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/tags?post=61753"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}